Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis

Leukemia

Volumn 11, Issue 11, 1997, Pages 1868-1877

  Xerri, L ^a,b   Devilard, E ^a,b   Hassoun, J ^a   Haddad, P ^c   Birg, F ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

^c Immunotech   (France)

Author keywords

Apoptosis; Cell sorting; Fas expression; Fas ligand expression; Human lymphoma; RT PCR

Indexed keywords

FAS ANTIGEN; MESSENGER RNA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL KILLING; CELL POPULATION; CONTROLLED STUDY; CROSS LINKING; ETIOLOGY; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; LYMPHOMA; LYMPHOMA CELL; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR BIOPSY;

EID: 0030687949     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400815     Document Type: Article

References (12)

1. Nagata S, Golstein P. The Fas Death Factor. Science 1995; 267: 1449-1456.
2. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponsting H, Krammer P. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 1992; 267: 10709-10715.
3. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
4. Armitage RD. Tumor necrosis factor receptor superfamily members and their ligands. Curr Biol 1994; 6: 407-413.
5. Debatin KM, Goldman CK, Bamford R, Waldmann TA, Krammer PH. Monoclonal antibody-mediated apotosis in adult T cell leukemia. Lancet 1990; 335: 497-500.
6. Debatin KM, Goldman CK, Waldmann TA, Krammer PH. APO-1 induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 1993; 81: 2972-2977.
7. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
8. Suda T, Nagata S. Purification and characterization of the Fas ligand that induces apoptosis. J Exp Med 1994; 179: 873-878.
9. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995, 14: 1129-1135.
10. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand: gene structure, chromosomal localization and species specificity. Int Immunol 1994; 6: 1567-1574.
11. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 56: 314-317.
12. Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K, Bhat D, Din W, Goodwin RG, Seldin MF. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1994; 1: 131-136.